CN101534843A - 泊洛沙姆用于预防和/或治疗心力衰竭的用途 - Google Patents
泊洛沙姆用于预防和/或治疗心力衰竭的用途 Download PDFInfo
- Publication number
- CN101534843A CN101534843A CNA2007800367818A CN200780036781A CN101534843A CN 101534843 A CN101534843 A CN 101534843A CN A2007800367818 A CNA2007800367818 A CN A2007800367818A CN 200780036781 A CN200780036781 A CN 200780036781A CN 101534843 A CN101534843 A CN 101534843A
- Authority
- CN
- China
- Prior art keywords
- poloxamer
- heart failure
- patient
- heart
- level
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/77—Polymers containing oxygen of oxiranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83472806P | 2006-08-01 | 2006-08-01 | |
| US60/834,728 | 2006-08-01 |
Related Child Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2013100791323A Division CN103222984A (zh) | 2006-08-01 | 2007-08-01 | 泊洛沙姆用于预防和/或治疗心力衰竭的用途 |
| CN2013101207279A Division CN103271935A (zh) | 2006-08-01 | 2007-08-01 | 泊洛沙姆用于预防和/或治疗心力衰竭的用途 |
| CN2011100477182A Division CN102218077A (zh) | 2006-08-01 | 2007-08-01 | 泊洛沙姆用于预防和/或治疗心力衰竭的用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101534843A true CN101534843A (zh) | 2009-09-16 |
Family
ID=38805633
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2007800367818A Pending CN101534843A (zh) | 2006-08-01 | 2007-08-01 | 泊洛沙姆用于预防和/或治疗心力衰竭的用途 |
| CN2013100791323A Pending CN103222984A (zh) | 2006-08-01 | 2007-08-01 | 泊洛沙姆用于预防和/或治疗心力衰竭的用途 |
| CN2011100477182A Pending CN102218077A (zh) | 2006-08-01 | 2007-08-01 | 泊洛沙姆用于预防和/或治疗心力衰竭的用途 |
| CN2013101207279A Pending CN103271935A (zh) | 2006-08-01 | 2007-08-01 | 泊洛沙姆用于预防和/或治疗心力衰竭的用途 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2013100791323A Pending CN103222984A (zh) | 2006-08-01 | 2007-08-01 | 泊洛沙姆用于预防和/或治疗心力衰竭的用途 |
| CN2011100477182A Pending CN102218077A (zh) | 2006-08-01 | 2007-08-01 | 泊洛沙姆用于预防和/或治疗心力衰竭的用途 |
| CN2013101207279A Pending CN103271935A (zh) | 2006-08-01 | 2007-08-01 | 泊洛沙姆用于预防和/或治疗心力衰竭的用途 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9155758B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2046348B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP5537152B2 (cg-RX-API-DMAC7.html) |
| CN (4) | CN101534843A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2007281531B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2659909A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2008016640A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101534843A (zh) | 2006-08-01 | 2009-09-16 | 普里克萨斯医药股份有限公司 | 泊洛沙姆用于预防和/或治疗心力衰竭的用途 |
| WO2008124088A2 (en) * | 2007-04-05 | 2008-10-16 | Phrixus Pharmaceuticals, Inc. | Compositions and methods for the treatment of heart failure |
| WO2011156389A2 (en) * | 2010-06-07 | 2011-12-15 | The Regents Of The University Of California | The islet amyloid polypeptide toxic oligomer is a biomarker of heart or kidney failure in type-2 diabetes mellitus |
| JP2016533377A (ja) * | 2013-10-16 | 2016-10-27 | マスト セラピューティクス インコーポレイテッドMast Therapeutics, Inc. | 利尿薬によって誘発される血漿量の変化 |
| AU2015287993B2 (en) | 2014-07-07 | 2020-10-29 | Liferaft Biosciences, Inc. | A poloxamer composition free of long circulating material and methods for production and uses thereof |
| US9757411B2 (en) | 2014-07-07 | 2017-09-12 | Aires Pharmaceuticals, Inc. | Poloxamer therapy for heart failure |
| WO2016007542A1 (en) * | 2014-07-07 | 2016-01-14 | Mast Therapeutics, Inc. | Poloxamer therapy for heart failure |
| JP7867990B2 (ja) * | 2020-07-09 | 2026-06-01 | ムスク・ファウンデイション・フォー・リサーチ・ディベロップメント | 傷害から細胞を保護する方法 |
| CN111973623B (zh) * | 2020-08-06 | 2022-04-05 | 温州医科大学 | 心力衰竭靶向治疗的速释制剂 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5198211A (en) | 1986-05-15 | 1993-03-30 | Emory University | Method of treating myocardial damage |
| US5733572A (en) | 1989-12-22 | 1998-03-31 | Imarx Pharmaceutical Corp. | Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles |
| EP0576612B1 (en) | 1991-03-19 | 1999-12-01 | Cytrx Corporation | Polyoxypropylene/polyoxyethylene copolymers with improved biological activity |
| WO1992022202A1 (en) | 1991-06-03 | 1992-12-23 | Alpha Therapeutics Corporation | Thrombolytic and perfluorochemical treatment for myocardial infraction |
| US5605687A (en) | 1992-05-15 | 1997-02-25 | Arch Development Corporation | Methods and compositions of a polymer (poloxamer) for repair of electrical injury |
| US5994348A (en) | 1995-06-07 | 1999-11-30 | Sanofi | Pharmaceutical compositions containing irbesartan |
| AU1312800A (en) | 1998-10-09 | 2000-05-01 | Cytrx Corporation | Method and composition for treating ischemia and sickle cell anemia |
| US20020013331A1 (en) | 2000-06-26 | 2002-01-31 | Williams Robert O. | Methods and compositions for treating pain of the mucous membrane |
| US6761824B2 (en) | 2000-08-17 | 2004-07-13 | Reeve Lorraine E | Process for the fractionation of polymers |
| EP1335707A4 (en) | 2000-10-24 | 2005-07-06 | Smithkline Beecham Corp | NEW CARVEDILOL FORMULATIONS |
| US7341552B2 (en) | 2002-03-15 | 2008-03-11 | The University Of Texas System Board Of Regents | Gene sets for glioma classification |
| US7550155B2 (en) | 2002-07-29 | 2009-06-23 | Transform Pharmaceuticals Inc. | Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses |
| WO2006037031A2 (en) | 2004-09-27 | 2006-04-06 | Valentis, Inc. | Formulations and methods for treatment of inflammatory diseases |
| US20060121016A1 (en) | 2004-10-18 | 2006-06-08 | Lee Raphael C | Methods and compositions for treatment of free radical injury |
| EP1853280B1 (en) | 2005-02-25 | 2012-02-22 | The Regents Of The University Of Michigan | Compositions and methods for treating and preventing cardiomyopathy and heart disease |
| PL1861080T3 (pl) | 2005-03-21 | 2010-10-29 | Santhera Pharmaceuticals Schweiz Ag | Idebenon do leczenia dystrofii mięśniowych |
| JP5745210B2 (ja) | 2006-02-03 | 2015-07-08 | ニコックス サイエンス アイルランド | 筋ジストロフィーの治療用薬剤のニトロオキシ誘導体の使用 |
| CN101534843A (zh) | 2006-08-01 | 2009-09-16 | 普里克萨斯医药股份有限公司 | 泊洛沙姆用于预防和/或治疗心力衰竭的用途 |
| WO2008124088A2 (en) | 2007-04-05 | 2008-10-16 | Phrixus Pharmaceuticals, Inc. | Compositions and methods for the treatment of heart failure |
| WO2009078978A2 (en) | 2007-12-14 | 2009-06-25 | Phrixus Pharmaceuticals, Inc. | Compositions containing polyglycidol-based polymers and uses thereof |
| EP2234625B8 (en) | 2007-12-17 | 2013-10-30 | The Regents of the University of Michigan | Compositions and methods for treating and preventing skeletal muscle deficiencies |
| WO2011066201A2 (en) | 2009-11-25 | 2011-06-03 | The Regents Of The University Of Michigan | Methods and systems for treating and preventing cardiac injury in dystrophic subjects |
-
2007
- 2007-08-01 CN CNA2007800367818A patent/CN101534843A/zh active Pending
- 2007-08-01 EP EP07810983.2A patent/EP2046348B1/en not_active Not-in-force
- 2007-08-01 AU AU2007281531A patent/AU2007281531B2/en not_active Ceased
- 2007-08-01 WO PCT/US2007/017182 patent/WO2008016640A2/en not_active Ceased
- 2007-08-01 US US12/309,803 patent/US9155758B2/en not_active Expired - Fee Related
- 2007-08-01 CN CN2013100791323A patent/CN103222984A/zh active Pending
- 2007-08-01 CN CN2011100477182A patent/CN102218077A/zh active Pending
- 2007-08-01 CN CN2013101207279A patent/CN103271935A/zh active Pending
- 2007-08-01 CA CA002659909A patent/CA2659909A1/en not_active Abandoned
- 2007-08-01 JP JP2009522861A patent/JP5537152B2/ja not_active Expired - Fee Related
-
2013
- 2013-09-12 JP JP2013189091A patent/JP2013253103A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| US20090246162A1 (en) | 2009-10-01 |
| EP2046348B1 (en) | 2015-07-22 |
| CN103222984A (zh) | 2013-07-31 |
| WO2008016640A2 (en) | 2008-02-07 |
| AU2007281531A1 (en) | 2008-02-07 |
| JP2013253103A (ja) | 2013-12-19 |
| CN103271935A (zh) | 2013-09-04 |
| WO2008016640A3 (en) | 2009-02-05 |
| CN102218077A (zh) | 2011-10-19 |
| JP5537152B2 (ja) | 2014-07-02 |
| US9155758B2 (en) | 2015-10-13 |
| CA2659909A1 (en) | 2008-02-07 |
| EP2046348A2 (en) | 2009-04-15 |
| AU2007281531B2 (en) | 2013-07-04 |
| JP2009545595A (ja) | 2009-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102218077A (zh) | 泊洛沙姆用于预防和/或治疗心力衰竭的用途 | |
| Ezekowitz et al. | Rationale and design of RE-LY: randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran | |
| JP6337170B2 (ja) | ネコの全身性疾患の予防又は治療の為のアンジオテンシンii受容体アンタゴニスト | |
| RU2518745C2 (ru) | Доставка октреотида из сухих лекарственных форм | |
| US20090176772A1 (en) | Method of reversing left ventricular remodeling | |
| CN102209529A (zh) | 将药物组合物递送至有需要的患者的方法 | |
| CN110167538B (zh) | 用于治疗心血管疾病的方法 | |
| US11197869B2 (en) | Istaroxime-containing intravenous formulation for the treatment of acute heart failure (AHF) | |
| AU2010214636A1 (en) | Compositions and methods for treating and preventing cardiomyopathy and heart disease | |
| Kasama et al. | Effects of perindopril on cardiac sympathetic nerve activity in patients with congestive heart failure: comparison with enalapril | |
| EP4511040A1 (en) | Istaroxime-containing intravenous formulation for the treatment of pre-cardiogenic shock and cardiogenic shock | |
| US9757411B2 (en) | Poloxamer therapy for heart failure | |
| US20060019954A1 (en) | Method for reducing the likelihood of the occurrence of cardiac arrhythmias | |
| CN116531363A (zh) | 甲基麦冬黄酮a在制备治疗心血管疾病药物中的应用 | |
| EA052076B1 (ru) | Комбинация зиботентана и дапаглифлозина для лечения хронического заболевания почек | |
| WO2009055421A1 (en) | Chimeric c3-like rho antagonist cardiac therapeutic |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20090916 |